.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
UBS
Dow
Queensland Health
Deloitte
US Department of Justice
AstraZeneca
McKinsey
Baxter
Argus Health

Generated: February 24, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Patent: 10305532

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Sanofi Us ServicesTOUJEO SOLOSTARinsulin glargine recombinantSOLUTION;SUBCUTANEOUS206538-001Feb 25, 2015RXYesYes➤ Try a Free Trial➤ Try a Free TrialYIMPROVEMENT IN GLYCEMIC CONTROL IN DIABETES MELLITUS PATIENTS
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist